Effects of Amino Acid Supplementation on Liver Lipid Content and Protein Metabolism in Obese Children
NCT02337894 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2025-10-02
Summary
The purpose of this study is to assess the effect of an eight-week dietary supplementation with essential amino acids plus arginine on liver and plasma lipid content, whole-body fat oxidation, whole-body insulin sensitivity, whole body protein metabolism, and body composition in obese pre-pubertal children.
Conditions
- Liver Steatosis
- Insulin Resistance
- Whole Body Protein Metabolism
- Body Composition, Beneficial
Interventions
- DIETARY_SUPPLEMENT
-
Essential amino acids plus arginine
Flavored drink containing essential amino acids plus arginine.
- DIETARY_SUPPLEMENT
-
Placebo
Flavored drink without essential amino acids plus arginine.
Sponsors & Collaborators
-
Arkansas Children's Hospital Research Institute
lead OTHER
Principal Investigators
-
Eva C Diaz, MD · University of Arkansas
-
Elisabet Borsheim, Ph.D · University of Arkansas
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 7 Years
- Max Age
- 10 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-01-30
- Primary Completion
- 2023-02-28
- Completion
- 2023-02-28
More Related Trials
-
Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease
NCT01191177 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Application and Effect Evaluation of Medium Chain Fatty Acid Rich Milk Powder in Infants With Cholestatic Liver Disease
NCT05922332 ·Status: WITHDRAWN ·Phase: NA
-
Compassionate Use of Omegaven in Children
NCT02370251 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD)
NCT00885313 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity
NCT02787668 ·Status: COMPLETED ·Phase: NA
-
Omegaven Protocol:Intermediate Size Patient Population
NCT03561194 ·Status: APPROVED_FOR_MARKETING
-
Efficacy and Safety of Omega-3 Lipid Therapy in Pediatric Patients With Parenteral Nutrition-Associated Liver Disease
NCT01739517 ·Status: UNKNOWN ·Phase: PHASE2
-
Use of Omega-3 Fat Emulsion (Omegaven) in Infants With Parenteral Nutrition Associated Liver Disease
NCT00862446 ·Status: COMPLETED ·Phase: PHASE4
-
Low Dose Fat for the Prevention of Liver Disease in Babies With Gastrointestinal Disorders
NCT01373918 ·Status: TERMINATED ·Phase: PHASE4
-
Fatty Liver Disease in Obese Children
NCT02117700 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Pilot Study of Acarbose as Treatment for Pediatric Non-alcoholic Fatty Liver Disease (NAFLD)
NCT00677521 ·Status: TERMINATED ·Phase: PHASE2
-
Effects of Carnitine Supplementation on Liver and Muscle
NCT03439917 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Omegaven™ Parenteral Nutrition in Patients With Total Parenteral Nutrition (TPN)-Induced Cholestasis
NCT00826020 ·Status: COMPLETED ·Phase: PHASE2
-
The Use of High Bile-binding Foods to Reduce Upper Gastrointestinal Bile Acid Concentrations (Aim 2)
NCT07303868 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Intravenous Fish Oils in the Treatment of Parenteral Nutrition Liver Injury
NCT02780193 ·Status: APPROVED_FOR_MARKETING
-
Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic
NCT04100109 ·Status: WITHDRAWN ·Phase: NA
-
Compassionate Use of Omegaven in the Treatment of Parenteral Nutrition Induced Hepatic Injury
NCT02010034 ·Status: COMPLETED ·Phase: NA
-
Aromatic Amino Acid Metabolism in the Pathogenesis of Kwashiorkor
NCT00429351 ·Status: COMPLETED
-
Hepatic Histopathology in Urea Cycle Disorders
NCT04908319 ·Status: RECRUITING
-
DHA and Vitamin D in Children With Biopsy-proven NAFLD
NCT02098317 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Combination Therapy Amino Acid L-CARNITINE and Magnesium on Fatty Liver
NCT03319199 ·Status: COMPLETED ·Phase: NA
-
Omegaven® in the Treatment of Parenteral Nutrition (PN) Induced Liver Injury
NCT01845116 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral Nutrition
NCT00004697 ·Status: COMPLETED ·Phase: NA
-
Compassionate Use of Omegaven® for the Treatment of Intestinal Failure Associated Liver Disease in Children
NCT02328768 ·Status: APPROVED_FOR_MARKETING
-
Omegaven Treatment of Parenteral Nutrition (PN) Induced Liver Injury
NCT01089426 ·Status: COMPLETED ·Phase: NA